Why technology standards are critical for Quantum-Safe Security

Safeguard Insights

March 11, 2010

Fourth Quarter and Fiscal 2009 Financial Disclosures Articulate 2010 Opportunities and Objectives

In our report for the period ended Dec. 31, 2009 that was released this morning, we updated investors on the significant progress achieved by Safeguard…

Posted by Peter J. Boni

March 10, 2010

Clarient Reports Improved Fourth Quarter and Fiscal 2009 Financial Performance

Safeguard Scientifics’ partner company Clarient (NASDAQ: CLRT) reported its fourth quarter (Dec. 31, 2009) and full-year 2009 financial results this afternoon. Clarient began 2010 with…

Posted by Stephen T. Zarrilli

February 23, 2010

An Overview of Our Partner Companies

Safeguard Scientifics’ strategy is to deploy capital in growth-stage companies in attractive sectors of the life sciences and technology industries. Within life sciences, we target…

Posted by Stephen T. Zarrilli

February 22, 2010

Molecular Biometrics Attracts Another $12.5 Million

Molecular Biometrics, Inc., one of Safeguard Scientifics’ Life Sciences partner companies, raised another $12.5 million of capital. The new capital will support three big goals.…

Posted by John E. Shave III

February 2, 2010

Safeguard Scientifics’ Jim Datin Discusses Biotech Investing Trends in 2010

James A. Datin, EVP and Managing Director of Safeguard Scientifics‘ Life Sciences Group, was recently interviewed by FierceBiotech, a leading industry online publication, about biotech…

Posted by John E. Shave III

January 21, 2010

Avid Radiopharmaceuticals Presents at J.P. Morgan Investor Conference

Safeguard Scientifics’ partner company Avid Radiopharmaceuticals was invited to present its technology and growth strategy at the prestigious J.P. Morgan 28th Annual Healthcare Conference in…

Posted by James A. Datin

January 12, 2010

Advanced BioHealing Profiled by Xconomy San Diego

Bruce Bigelow of Xconomy San Diego highlights Advanced BioHealing’s (ABH) commercial success with Dermagraft in his article. Bigelow details the success of Dermagraft and ABH’s…

Posted by James A. Datin